inavolisib Search Results


gdc 0077  (MedChemExpress)
94
MedChemExpress gdc 0077
Inhibition of cervical cancer cell lines by PI3K α inhibitors. The maximum dose for each cell line was selected, and the percentage inhibition was compared with the corresponding control. (A) Alpelisib (BYL-719). (B) Inavolisib <t>(GDC-0077).</t> All cell lines have PIK3CA mutations except SiHa. **** = p < 0.0001 by one-way ANOVA and Dunnett’s multiple comparison test. <20% inhibition interpreted as no or negative response.
Gdc 0077, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inavolisib/Inavolisib/pmc13092703-52-0-5
Average 94 stars, based on 1 article reviews
gdc 0077 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
inavolisib  (MuseChem Chemicals)
N/A
GDC-0077 (Cat No.:I006937) is a highly selective inhibitor of the PI3K alpha (PI3Kα) isoform, which plays a crucial role in cell growth, proliferation, and survival. PI3Kα is frequently mutated in several cancers, including breast cancer,
   Buy from Supplier
inavolisib gdc-077  (Genentech inc)
90
Genentech inc inavolisib gdc-077
Inhibition of cervical cancer cell lines by PI3K α inhibitors. The maximum dose for each cell line was selected, and the percentage inhibition was compared with the corresponding control. (A) Alpelisib (BYL-719). (B) Inavolisib <t>(GDC-0077).</t> All cell lines have PIK3CA mutations except SiHa. **** = p < 0.0001 by one-way ANOVA and Dunnett’s multiple comparison test. <20% inhibition interpreted as no or negative response.
Inavolisib Gdc 077, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inavolisib/inavolisib/us11878958-790-9-11
Average 90 stars, based on 1 article reviews
inavolisib gdc-077 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
inavolisib (mpi3k)  (Genentech inc)
90
Genentech inc inavolisib (mpi3k)
Inhibition of cervical cancer cell lines by PI3K α inhibitors. The maximum dose for each cell line was selected, and the percentage inhibition was compared with the corresponding control. (A) Alpelisib (BYL-719). (B) Inavolisib <t>(GDC-0077).</t> All cell lines have PIK3CA mutations except SiHa. **** = p < 0.0001 by one-way ANOVA and Dunnett’s multiple comparison test. <20% inhibition interpreted as no or negative response.
Inavolisib (Mpi3k), supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inavolisib/inavolisib++mpi3k+/pm40501288-21-14-3
Average 90 stars, based on 1 article reviews
inavolisib (mpi3k) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
pi3kalpha inhibitor inavolisib  (Genentech inc)
90
Genentech inc pi3kalpha inhibitor inavolisib
Inhibition of cervical cancer cell lines by PI3K α inhibitors. The maximum dose for each cell line was selected, and the percentage inhibition was compared with the corresponding control. (A) Alpelisib (BYL-719). (B) Inavolisib <t>(GDC-0077).</t> All cell lines have PIK3CA mutations except SiHa. **** = p < 0.0001 by one-way ANOVA and Dunnett’s multiple comparison test. <20% inhibition interpreted as no or negative response.
Pi3kalpha Inhibitor Inavolisib, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/inavolisib/pi3kalpha+inhibitor+inavolisib/pm38518961-60-5-28
Average 90 stars, based on 1 article reviews
pi3kalpha inhibitor inavolisib - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
inavolisib  (TargetMol)
N/A
   Buy from Supplier

Image Search Results


Inhibition of cervical cancer cell lines by PI3K α inhibitors. The maximum dose for each cell line was selected, and the percentage inhibition was compared with the corresponding control. (A) Alpelisib (BYL-719). (B) Inavolisib (GDC-0077). All cell lines have PIK3CA mutations except SiHa. **** = p < 0.0001 by one-way ANOVA and Dunnett’s multiple comparison test. <20% inhibition interpreted as no or negative response.

Journal: Neoplasia (New York, N.Y.)

Article Title: PIK3CA mutant cervical cancer is selectively suppressed by PI3Kα inhibition (Alpelisib/BYL-719 and Inavolisib/GDC-0077) and cooperates with HPV directed T cell therapy

doi: 10.1016/j.neo.2026.101305

Figure Lengend Snippet: Inhibition of cervical cancer cell lines by PI3K α inhibitors. The maximum dose for each cell line was selected, and the percentage inhibition was compared with the corresponding control. (A) Alpelisib (BYL-719). (B) Inavolisib (GDC-0077). All cell lines have PIK3CA mutations except SiHa. **** = p < 0.0001 by one-way ANOVA and Dunnett’s multiple comparison test. <20% inhibition interpreted as no or negative response.

Article Snippet: GDC-0077 was also purchased from MedChem Express (Cat# HY-101562.

Techniques: Inhibition, Control, Comparison